Ally Bridge Group NY LLC acquired a new stake in Eliem Therapeutics, Inc. (NASDAQ:ELYM - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 500,000 shares of the company's stock, valued at approximately $3,555,000. Eliem Therapeutics makes up approximately 2.1% of Ally Bridge Group NY LLC's investment portfolio, making the stock its 24th biggest holding. Ally Bridge Group NY LLC owned 1.68% of Eliem Therapeutics as of its most recent filing with the Securities and Exchange Commission.
https://www.marketbeat.com/instant-alerts/nasdaq-elym-sec-filing-2024-09-23/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.